SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-043877
Filing Date
2007-03-01
Accepted
2007-03-01 12:23:20
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1431884
2 SUBSIDIARIES OF THE COMPANY dex211.htm EX-21.1 2368
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 9155
4 CERTIFICATION OF PEO PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 5904
5 CERTIFICATION OF PAO PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 5872
6 CERTIFICATION BY THE PEO AND PAO PURSUANT TO SECTION 1350 dex321.htm EX-32.1 3430
7 GRAPHIC g95240img001.jpg GRAPHIC 10914
8 GRAPHIC g95240img002.jpg GRAPHIC 59956
  Complete submission text file 0001193125-07-043877.txt   1558041
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19756 | Film No.: 07661577
SIC: 2836 Biological Products, (No Diagnostic Substances)